WallStSmart

JBS N.V. (JBS)vsThe Marzetti Company (MZTI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 4624% more annual revenue ($91.17B vs $1.93B). MZTI leads profitability with a 9.9% profit margin vs 1.2%. JBS trades at a lower P/E of 12.5x. MZTI earns a higher WallStSmart Score of 57/100 (C).

JBS

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 6.0Value: 6.0Quality: 6.0
Piotroski: 6/9Altman Z: 2.62

MZTI

Buy

57

out of 100

Grade: C

Growth: 5.3Profit: 7.0Value: 4.0Quality: 8.0
Piotroski: 3/9Altman Z: 3.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for JBS.

MZTISignificantly Overvalued (-29.9%)

Margin of Safety

-29.9%

Fair Value

$120.18

Current Price

$104.05

$16.13 premium

UndervaluedFair: $120.18Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JBS3 strengths · Avg: 8.7/10
Return on EquityProfitability
77.9%10/10

Every $100 of equity generates 78 in profit

P/E RatioValuation
12.5x8/10

Attractively priced relative to earnings

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

MZTI5 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0610/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.2010/10

Safe zone — low bankruptcy risk

P/E RatioValuation
14.9x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

EPS GrowthGrowth
49.5%8/10

Earnings expanding 49.5% YoY

Areas to Watch

JBS4 concerns · Avg: 2.3/10
Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Operating MarginProfitability
3.1%3/10

Operating margin of 3.1%

EPS GrowthGrowth
-57.2%2/10

Earnings declined 57.2%

Debt/EquityHealth
2.971/10

Elevated debt levels

MZTI3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.122/10

Expensive relative to growth rate

Revenue GrowthGrowth
-2.2%2/10

Revenue declined 2.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : JBS

The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.

Bull Case : MZTI

The strongest argument for MZTI centers on Debt/Equity, Altman Z-Score, P/E Ratio.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, Operating Margin, EPS Growth. Debt-to-equity of 2.97 is elevated, increasing financial risk. Thin 1.2% margins leave little buffer for downturns.

Bear Case : MZTI

The primary concerns for MZTI are Piotroski F-Score, PEG Ratio, Revenue Growth.

Key Dynamics to Monitor

JBS is growing revenue faster at 13.8% — sustainability is the question.

JBS generates stronger free cash flow (240M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MZTI scores higher overall (57/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

The Marzetti Company

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Marzetti Company engages in the manufacturing and marketing of specialty food products for the retail and foodservice channels in the United States. The company is headquartered in Westerville, Ohio.

Visit Website →

Want to dig deeper into these stocks?